Can-Fite BioPharma Files Form 6-K for May 2024
Ticker: CANF · Form: 6-K · Filed: May 22, 2024 · CIK: 1536196
| Field | Detail |
|---|---|
| Company | Can-Fite Biopharma LTD. (CANF) |
| Form Type | 6-K |
| Filed Date | May 22, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Can-Fite BioPharma filed a 6-K for May, incorporating into existing SEC filings.
AI Summary
On May 22, 2024, Can-Fite BioPharma Ltd. filed a Form 6-K, incorporating this report into its existing S-8 and F-3 registration statements. The filing is for the month of May 2024 and pertains to its status as a foreign private issuer. Can-Fite BioPharma Ltd. is incorporated in Israel and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing updates the SEC on Can-Fite BioPharma's ongoing reporting obligations as a foreign private issuer, which is crucial for investors tracking the company's regulatory compliance and disclosures.
Risk Assessment
Risk Level: low — This is a routine reporting form (6-K) and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- Can-Fite BioPharma Ltd. (company) — Registrant
- 0001213900-24-045904 (filing_id) — Accession Number
- May 2024 (date) — Reporting Period
- 20240522 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
Which registration statements does this 6-K filing get incorporated into?
This Form 6-K is incorporated by reference into Can-Fite BioPharma Ltd.'s Registration Statements on Form S-8 (File Nos. 333-227753, 333-271384 and 333-278525) and Form F-3 (File Nos. 333-195124, 333-236064, 333-249063, 333-262055 and 333-276000).
What is Can-Fite BioPharma Ltd.'s primary business sector?
Can-Fite BioPharma Ltd. operates in the Pharmaceutical Preparations sector, with the Standard Industrial Classification code 2834.
Where is Can-Fite BioPharma Ltd. headquartered?
Can-Fite BioPharma Ltd.'s principal executive offices are located at 10 Bareket Street, Kiryat Matalon, P.O. Box 7537, Petach-Tikva 4951778, Israel.
What is the filing date of this Form 6-K?
This Form 6-K was filed on May 22, 2024.
Filing Stats: 438 words · 2 min read · ~1 pages · Grade level 11 · Accepted 2024-05-22 16:15:19
Filing Documents
- ea0206358-6k_canfite.htm (6-K) — 14KB
- ea020635801ex99-1_canfite.htm (EX-99.1) — 110KB
- ea020635801ex99-2_canfite.htm (EX-99.2) — 28KB
- ea020635801ex99-3_canfite.htm (EX-99.3) — 2KB
- ex99-1_001.jpg (GRAPHIC) — 10KB
- ex99-3_001.jpg (GRAPHIC) — 179KB
- ex99-3_002.jpg (GRAPHIC) — 126KB
- 0001213900-24-045904.txt ( ) — 590KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: May 22, 2024 By: /s/ Motti Farbstein Motti Farbstein Chief Executive Officer and Chief Financial Officer 2